Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
van de Kerkhof PC, Hoffmann V, Anstey A, Barnes L, Bolduc C, Reich K, Saari S, Segaert S, Vaillant L. van de Kerkhof PC, et al. Among authors: barnes l. Br J Dermatol. 2009 Jan;160(1):170-6. doi: 10.1111/j.1365-2133.2008.08927.x. Epub 2008 Nov 25. Br J Dermatol. 2009. PMID: 19067709 Clinical Trial.
The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.
de Jong EM, Mørk NJ, Seijger MM, De La Brassine M, Lauharanta J, Jansen CT, Guilhou JJ, Guillot B, Ostrojic A, Souteyrand P, Vaillant L, Barnes L, Rogers S, Klaber MR, Van De Kerkhof PC. de Jong EM, et al. Among authors: barnes l. Br J Dermatol. 2003 Feb;148(2):318-25. doi: 10.1046/j.1365-2133.2003.05173.x. Br J Dermatol. 2003. PMID: 12588386 Clinical Trial.
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Jolliffe D, Peyri J, Svensson A, Toole J, Wozel G. Kragballe K, et al. Among authors: barnes l. Br J Dermatol. 2006 Jun;154(6):1155-60. doi: 10.1111/j.1365-2133.2006.07236.x. Br J Dermatol. 2006. PMID: 16704648 Clinical Trial.
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Williams Z, Peyri Rey J, Svensson A, Toole J, Wozel G. Kragballe K, et al. Among authors: barnes l. Dermatology. 2006;213(4):319-26. doi: 10.1159/000096069. Dermatology. 2006. PMID: 17135738 Clinical Trial.
Topical corticosteroid treatment: systemic side-effects.
Kane D, Barnes L, Fitzgerald O. Kane D, et al. Among authors: barnes l. Br J Dermatol. 2003 Aug;149(2):417. doi: 10.1046/j.1365-2133.2003.05356.x. Br J Dermatol. 2003. PMID: 12932255 No abstract available.
1,337 results